Torax Medical nets $25 mln Series B

St. Paul, Minnesota-based Torax Medical Inc, a maker of products that treat sphincter disorders, has closed $25 million in Series E financing. Johnson & Johnson Innovation – JJDC Inc led the round with participation from other investors that included Sanderling Ventures, Thomas McNerney & Partners, Accuitive Medical Ventures, Kaiser Permanente Ventures, Piper Jaffray Companies and Mayo Clinic Ventures. In addition to the funding, Torax has hired Chas McKhann as chief commercial officer. Previously, McKhann worked at Intersect ENT where he served as chief commercial officer.

Briefs